Related Experiment Video
Updated: Jul 10, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency
Diletta Giovenale1, Cristina Meazza, Giuliana M Cardinale
1Department of Pediatric Science, Università degli Studi di Pavia, Fondazione IRCCS San Matteo, Pavia, Italy.
Insights
Growth hormone (GH) therapy effectively promotes catch-up growth in children with celiac disease (CD) and GH deficiency (GHD) on a gluten-free diet. The treatment
Area of Science:
- Pediatric Endocrinology
- Gastroenterology
- Metabolic Disorders
Background:
- Celiac disease (CD) can be associated with growth hormone deficiency (GHD), impacting linear growth in children.
- Adequate gluten-free diet (GFD) adherence is crucial for managing CD but may not always restore normal growth in GHD patients.
- Evaluating growth response to GH therapy in CD with GHD is essential for optimizing treatment strategies.
Purpose of the Study:
- To assess the efficacy of growth hormone (GH) replacement therapy in prepubertal children with celiac disease (CD) and GH deficiency (GHD).
- To compare the growth response in CD/GHD patients on a gluten-free diet with those having idiopathic GHD (IGHD).
Main Methods:
- A cohort of 14 prepubertal children with CD and GHD, unresponsive to GFD alone, were studied.
- 10 age-matched children with idiopathic GHD (IGHD) served as a control group.
- All participants received a standardized weekly dose of GH (0.25 mg/kg) for three years, with regular monitoring of height, growth rate, and BMI.
Main Results:
- GH therapy significantly increased growth rates in the first year for both CD/GHD and IGHD groups (P < 0.005).
- Growth rates remained positive in the third year, indicating sustained catch-up growth in both cohorts.
- The growth response to GH treatment was comparable between children with CD/GHD on a GFD and those with IGHD.
Conclusions:
- GH replacement therapy is recommended for children with CD and GHD who do not achieve catch-up growth on a gluten-free diet.
- GH treatment demonstrates comparable efficacy in promoting growth in CD/GHD patients adhering to a GFD as in IGHD patients.
- This suggests that GH therapy is a viable option for optimizing growth outcomes in this specific pediatric population.
Objective:
To evaluate the growth response to growth hormone (GH) replacement therapy during a gluten-free diet in patients with celiac disease (CD) associated with GH deficiency (GHD).
Patients And Methods:
A total of 14 prepubertal children affected by CD and GHD with no catch-up growth after >/=12 months of gluten-free diet and a reversion to seronegativity for antiendomysium antibodies and 10 age-matched prepubertal children with idiopathic GHD (IGHD) entered the study. All of the patients were treated with the same GH dosage (0.25 mg/kg subcutaneously each week). Height, growth rate, and body mass index were measured at the time of diagnosis of CD, at the time of endocrinological evaluation, and after the first, second, and third year of GH replacement therapy.
Results:
Growth rate strikingly increased (P < 0.005) during the first year of therapy in a similar way in subjects with CD/GHD and IGHD (from a median standard deviation score [SDS] of -2.34 to an SDS of 3.25 and from an SDS of -1.29 to an SDS of 2.79, respectively). During the second and third years of GH treatment, the growth rate tended to decrease but the values at the third year were always positive (CD/GHD, median SDS, 1.10; IGHD, median SDS, 0.11), indicating continued catch-up growth.
Conclusions:
In patients with CD with GH deficiency confirmed after >/=12 months of gluten-free diet, GH replacement therapy should be started to allow complete catch-up growth in children. In addition, the effect of GH treatment in patients who comply with a gluten-free diet seems to be comparable to that observed in children with IGHD.
Related Concept Videos
Nature and Nurture
Hypoglycemia and Glucagon
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.